Please login to the form below
accessibility
This page shows the latest accessibility news and features for those working in and with pharma, biotech and healthcare.
Key emerging trends in digital health
From the ever-increasing availability of new apps aiming to help the management of chronic disease to the increasing popularity of video doctor appointments, digital technologies offer improved accessibility and ease
Latest news
-
LifeArc creates £10m COVID-19 research fund
on the manufacture and accessibility of the drug.
-
Immuno-oncology, personalised medicine continues to drive pharma sector
Despite being the top trends affecting the industry this year, there has been a lot of scepticism surrounding the accessibility of novel I-O therapies and personalised treatments.
-
Origin opens new facility in Alderley Park
It’s a fantastic opportunity to support the next generation of UK pharma companies and create accessibility for them to drop in and engage with our packaging technologists,” he added.
-
Gyroscope advances gene therapy platform, merges with Orbit
Eye conditions have emerged as one of the leading areas for gene therapy - thanks to factors such as the eye's easy accessibility, it being a highly compartmentalised and immune-privileged
-
Improving childhood cancer survival rates in developing countries
Accessibility to cancer drugs is also unreliable within LMICs as a result of irregular procurement and importation by each country’s regulatory system.
More from news
Approximately 1 fully matching, plus 63 partially matching documents found.
Latest Intelligence
-
How can we realise the benefits of patient engagement?
vital; information must be shared in lay terms so all parties can contribute in an informed way; accessibility must be assessed to ensure there are no barriers to participation, and patients
-
Lonely planet: why there is dwindling value in pharma travelling alone
data. The importance of real-world data is growing rapidly, but its quality, taxonomy and accessibility are not standardised and once again require collaboration to pull it off.
-
China: AstraZeneca’s new engine for growth and innovation
If we can do that, we can help create an open, collaborative and innovative healthcare ecosystem, and increase the accessibility and efficiency of healthcare services in China.”. ... Earlier this year, it unveiled new partnerships with tech giants
-
Creating a successful global compliance programme
The DOJ reiterated the importance of certain elements and controls, such as the design, accessibility and communication of policies and procedures, providing ‘gatekeepers’ (persons with the authority to issue payments or
-
A catalyst for change
China’s plan to boost innovation and improve drug accessibility. In the past decade, the unreasonably long drug approval period in China (often up to six or seven years) had been ... The government is now determined to establish an efficient drug
More from intelligence
Approximately 0 fully matching, plus 22 partially matching documents found.
Latest appointments
-
Changes at Oxford PharmaGenesis, Synergy Vision and akt health communications
underpinned by relevant local knowledge and accessibility for clients around the world.
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
COUCH Health, embarks on a 3-year long mission to improve 1 million lives
Our desire to improve health information, education and accessibility - and ultimately improve lives - is driven by my personal experiences, but is something the entire team at COUCH has bought in to.
-
Who’s winning at digital transformation? (And who failed to adapt…)
With unique accessibility data and the latest digital tools, we flexibly deploy exceptional sales professionals in Market Access, Secondary Care, Primary Care and Commercial projects.
-
Is Dr Google a 21st-century necessity?
But as the internet is here to stay, does the current focus on highlighting the pitfalls to the public need to shift to a focus on the accessibility and reliability of
-
NHS Long Term Plan - Digital is firmly on the agenda. Are you ready?
Our unique accessibility data along with the latest digital tools allows us to flexibly deploy exceptional sales professionals in Market Access, Secondary Care, Primary Care projects.
-
What Pharma can learn from B2B digital trends
Our unique accessibility data along with the latest digital tools allows us to flexibly deploy exceptional sales professionals in Market Access, Secondary Care, Primary Care projects.
More from PMHub
Approximately 0 fully matching, plus 12 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- GSK plans to produces one billion doses of vaccine adjuvant for COVID-19
- EMA clears BMS’ oral multiple sclerosis drug Zeposia
- Roche/Gilead tag team fights COVID-19 with Actemra/remdesivir
- Merck’s Keytruda hits the mark in triple negative breast cancer
- Finalists 2020 - Communiqué Awards
- ASCO: Momentum gathers behind next wave of CAR-T therapies
- Lilly starts world first trial of an antibody drug for COVID-19
- Pfizer’s Ibrance misses the mark in early breast cancer
- Rise of the patient influencer
- Working together against COVID-19
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- Working together against COVID-19
- Analysing social media conversations to see what HCPs are saying online about the global pandemic...
- Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
- Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....
Quick links
Infographics
